CN1507892A - Osteoproliferation medicine for external application - Google Patents
Osteoproliferation medicine for external application Download PDFInfo
- Publication number
- CN1507892A CN1507892A CNA021455759A CN02145575A CN1507892A CN 1507892 A CN1507892 A CN 1507892A CN A021455759 A CNA021455759 A CN A021455759A CN 02145575 A CN02145575 A CN 02145575A CN 1507892 A CN1507892 A CN 1507892A
- Authority
- CN
- China
- Prior art keywords
- hyperosteogeny
- ethanol
- impatientis
- folium
- mainly comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The present invention relates to a medicine for external application for curing hyperosteogeny. Its prescription comprises (wt%) impatients balsamina 1-3%, murraya exotica 1-3%, house lizard 1-2%, drynaria root 2-3% and ethyl alcohol 80-65%, also can include borneol 1-1.5%. SAid medicine for external application can be made into the form of medicinal liquor, and can obtain obvious therapeutic effect for curing hyperosteogeny and rheumatism.
Description
Technical field: the invention belongs to a kind of Chinese medicine preparation, particularly about treating the pure Chinese medicine liquid medicated wine externally dressing of hyperosteogeny.
Technical background: hyperosteogeny is to move back with articular cartilage to draw the disease that sexually revises, and is a kind of frequently-occurring disease, commonly encountered diseases, suffers from middle-aged and elderly people more, and diseased region has more positions such as present cervical vertebra, lumbar vertebra, knee joint.
The pathogeny modern medicine of hyperosteogeny thinks that this disease is a kind of osteoarthritis, is to move back with articular cartilage to draw the disease that sexually revises, and joint part forms the protruding thing that has more normal structure, is commonly called as " bony spur ".Diseased region occurs in limbs joint, and then visible joint space narrows down, and articular surface flattens, articular surface broadening flattens, and joint edge contour sharpen can have hyperostosis to generate microcheilia shape projection, or one-tenth bony spur, make joint motion limited, pain occurs, diseased region occurs in vertebra, and then as seen to bore the gap asymmetric and narrow, there is the hyperosteogeny of lip shape at the edge, little joint also has hyperosteogeny to form between spinal column, and intervertebral foramina is narrowed down, and pressuring neural root then produces radiated pain.Diseased region occurs in cervical vertebra, and nerve compression compels then to occur the strong pain of cervical region, and hands shoulder back of the body numbness is ached, and the vertigo then appears in the vertebral artery pressurized, even nausea and vomiting and visual system are hindered.Diseased region occurs in waist and lumbago then occurs, and numbness of lower limbs is ached, and this disease is inconvenient activity then gently, and is heavy then be unable to leave the bed, and loses movable function.
Show according to statistics, the hyperosteogeny occurrence rate is high, the development of paathogenic factor with advancing age, clinically occur that the symptom rate is also corresponding to be increased, with the lumbar vertebra be example more than 50 years old the X line hyperosteogeny to occur be more than 90% the male, women 41-50 year is to be 100% more than 95.7%, 51 years old, what before finding in the research of other 100 example headache numbness of hand and 100 routine lumbago and skelalgia cases hyperosteogeny formation is arranged is 67 examples, and the latter is 60 examples.
Aspect clinical treatment, the doctor trained in Western medicine operation can not be effected a radical cure, and takes massage more, traction, therapies such as acupuncture point block, can only play mitigation, the Chinese medicine preparation of existing market sale and clinical practice, unsatisfactory curative effect or DeGrain, the patient groans deeply, this disease is had disheartened attitude, think that this disease does not have what good treatment way, the appearance of very urgent a kind of special effect medicine of hope.
The traditional Chinese medical science thinks that this disease belongs to arthromyodynia " rheumatism involving the bone " category, how because of caused by liver and kidney deficiency, insufficiency of vital energy and blood, wind, cold, three gas close and assorted most numbness makes QI-blood circulation not smooth, blockage of main and collateral channels, the resistance of muscle BI-syndrome involved the blood vessels, joint are lost and are supported, and cause this disease.
The purpose of this invention is to provide a kind of hyperosteogeny application compress, its treatment hyperosteogeny and rheumatism adopt externally dressing, its good effect, mitigate the disease rapidly, play therapeutical effect at short notice, thereby reach the purpose of curing rehabilitation, make the patient avoid long-term incurable misery.
Technical scheme of the present invention is: design a kind of hyperosteogeny application compress, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Ethanol 80-65%.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Ethanol 80-65%.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Ethanol 80-65%.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5%; Ethanol 80-65%.
Raw material powder is broken into fine powder to be crossed 300 mesh sieves and then medicated powder is soaked into for 75% ethanol 1-2 week.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Ethanol 80-65%.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Ethanol 80-65%.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Scorpio 1-1.5%; Eupolyphaga 1-1.5%; Ethanol 80-65%.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Scorpio 1-1.5%; Eupolyphaga 1-1.5%; Camphora 1-1.5%; Radix Angelicae Sinensis 1-1.5%; Pyritum 0.5-1%; Ethanol 80-65%.
It mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Scorpio 1-1.5%; Eupolyphaga 1-1.5%; Camphora 1-1.5%; Radix Angelicae Sinensis 1-1.5%; Pyritum 0.5-1%; Radix Angelicae Pubescentis 0.5-1%; Flos Carthami 0.5-1%; Ethanol 80-65%.
Prescription medicine efficiency analysis: Impatientis: sweet, warm, expelling wind and activating blood circulation, reducing swelling and alleviating pain, softening the hard mass are deep, and modern pharmacological research shows the effect with softening bony spur.Folium Et Cacumen Murrayae: hot, bitter, warm in nature, circulation of qi promoting dehumidifying, eliminating stasis to stop pain.Herba speranskiae tuberculatae: acrid in the mouth, warm in nature, have the effect of expelling wind and removing dampness, channels sootheing and network vessel quickening, promoting blood circulation and stopping pain.Rhizoma Drynariae: bitter, warm, the kidney invigorating, promoting blood circulation, removing blood stasis and relieving pain, modern pharmacological research show the effect that has softening bony spur, suppresses bony spur formation.Succinum: sweet, flat, dissipating blood stasis hemostasis, Gekko Swinhonis: expelling wind for relieving convulsion, powder detoxifcation, modern pharmacology the analysis showed that the effect with softening bony spur.Radix Clematidis: hot, warm, wind-damp dispelling, the meridian dredging, stopping numbness pain, modern pharmacology the analysis showed that to have obviously softening bony spur, improve local inflammation, eliminate the effect of edema, Olibanum: the little hardship of acrid in the mouth, promoting blood circulation and stopping pain, detumescence and promoting granulation.Eupolyphaga: acrid in the mouth, little bitterness temperature, promoting blood circulation to remove blood stasis, reunion of fractured tendons and bones.Sanguis Draxonis: salty, flat, the promoting blood circulation to remove blood stasis pain relieving.Myrrha: the little hardship of acrid in the mouth, warm in nature, promoting blood circulation and stopping pain, detumescence and promoting granulation.Scorpio: hot flat, endogenous wind stopping relieving convulsion, detoxicating and resolving stagnation of pathogens, collateral dredging end, and pharmacology analysis shows to have the effect that improves the muscle spasm and pain.Radix Angelicae Sinensis: Gan Xin, warm in nature, enrich blood, promoting blood circulation and stopping pain.Borneolum Syntheticum: hot, bitter, cool in nature, reducing swelling and alleviating pain.Camphora: hot, analgesia, make a general survey of the effect that the top has tangible dispelling wind and removing obstruction in the collateral, blood-activating analgetic, softening bony spur.
The function of this prescription and curing mainly: function: expelling wind and cold, channels sootheing and network vessel quickening, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, softening bony spur.Cure mainly: hyperosteogeny, rheumatism, rheumatoid arthritis, scapulohumeral periarthritis, sciatica, lumbar spinal stenosis, prolapse of intervertebral disc and lumbar muscle strain, traumatic injury, etc. disease.
This characteristic feature of an invention: 1, pure Chinese medicinal preparation has no side effect.2, externally dressing directly acts on diseased region, absorbs by skin histology, and the focus that can directly become is dispeled old complaint.3, use the medicine composition uniqueness, drug effect is superpower lasting, efficient infiltration, and reducing swelling and alleviating pain improves the tissue circulation rapidly.4, short treating period, instant effect makes hyperplastic tissue can be absorbed branch in short-term and takes off.
General hyperosteogeny and rheumatic sufferers can be cured in course of treatment of medication.Total effective rate 100%, cure rate 90.2%, 5, easy to use simple and direct, the patient avoids the misery of having an injection for a long time, take medicine, draw, massaging.
Clinical verification is for many years passed through in this invention, and aspect diseases such as treatment hyperosteogeny, rheumatism, rheumatoid, kinds of Diseases that sum up and curative effect data are as follows:
Disease | Case load | Recovery from illness | Remarkable result | General effect | Invalid | Effective percentage |
Hyperosteogeny | ????80 | ????74 | ????74 | ????1 | ????0 | ??100% |
Rheumatism | ????50 | ????48 | ????48 | ????2 | ????0 | ??100% |
Rheumatoid | ????60 | ????47 | ????54 | ????4 | ????2 | ??96.6% |
Kinds of Diseases and the course of treatment catalog:
Disease | Case load | Healing time | ||||
Two weeks | Three weeks | Five weeks | Six weeks | Eight weeks | ||
Hyperosteogeny | ????80 | ????60 | ????3 | ????2 | ????6 | ????3 |
Rheumatism | ????50 | ????40 | ????4 | ????2 | ????1 | ????1 |
Rheumatoid | ????60 | ????7 | ????6 | ????10 | ????11 | ????13 |
The present invention will be further described below in conjunction with embodiment:
The composition and the proportion of the specific embodiment: embodiment 1 medicine are as follows:
Impatientis 3%; Folium Et Cacumen Murrayae 3%; Herba speranskiae tuberculatae 2%; Gekko Swinhonis 1%; Radix Clematidis 2%; Olibanum 1.5%; Myrrha 1.5%; Sanguis Draxonis 1%; Rhizoma Drynariae 3%; Succinum 1%; Borneolum Syntheticum 1.5%; Radix Cyathulae 1.5% was pulverized 300 mesh sieves to above medicine by proportion, was soaked in 78% part of 75% the ethanol, and in 1-2 week, stir 1-3 every day, and precipitation goes medicinal residues to filter to divide to install in the 250ML bottle to get final product then.
The composition and the proportion of embodiment 2 medicines are as follows: Impatientis 3%; Folium Et Cacumen Murrayae 3%; Herba speranskiae tuberculatae 2%; Scorpio 1%; Eupolyphaga 1%; Gekko Swinhonis 2%; Radix Clematidis 2%; Olibanum 1.5%; Myrrha 1.5%; Sanguis Draxonis 1%; Rhizoma Drynariae 3%; Succinum 1%; Borneolum Syntheticum 1.5%, Radix Cyathulae 1.5% was pulverized 300 mesh sieves to above medicine by proportion, was soaked in 75% part of 75% the ethanol, and in 1-2 week, stir 1-3 every day, and precipitation goes medicinal residues to filter to divide to install in the 250ML bottle to get final product then.
Clinical observation result:
1, fourth so-and-so, man, 74 years old, live Lianhu District king of medicine hole, Xi'an No. 164: the patient suffers from the lumbar vertebra hyperosteogeny more than two decades, and with the lumbar vertebra outmoded injury, the symptom performance, lumbago, left lower limb radioactivity numb pain has a strong impact on daily life, treatment throughout the year can not be cured, through using this medicine, symptom thoroughly disappears after 20 days, has now cured rehabilitation.
2, Lv, the woman 68 years old now, lives paper mill family members institute of the new Qin in Baoji.Patient main suit oneself suffers from rheumatic arthritis and two kneecap matter hypertrophy 25 years, joint deformity, stiff, can not bend and stretch, pain unbearably, reluctantly 20 meters of the walkings of post cane, through treating three courses of treatment with this medicine, transference cure, activity are taken care of oneself freely, clinical cure was not seen recurrence in 3 years so far.
3, Lee: man, 43 years old, live unity village, Guanji township, Zhouzhi County, Xi'an, suffered from hyperosteogeny of cervical vertebra 5 years, main suit's dizziness, left hand numb pain, therapeutic effect is not good for many years, and through with course of treatment of this medicine, transference cure, clinical cure were not seen recurrence in 2 years so far.
4, Zhang: man, 52 years old, live Er Qu town, Zhouzhi County, Xi'an, suffered from hyperosteogeny of cervical vertebra 6 years, through treating poor effect for many years.Main suit's dizziness, cervical region are strong, and right shoulder and right arm numbness are ached.Through with two courses of treatment of this medicine external application, transference cure is followed up a case by regular visits to and is seen recurrence, now rehabilitation the year ends three.
5, Chen, woman, 46 years old live the Lintong District, Xi'an, suffer from third and fourth joint hyperosteogeny of lumbar vertebra 5 years, through treating the end commentaries on classics of getting better for many years.Main suit's lumbago, left lower limb radioactivity numb pain with this medicine external application affected part every day twice, are cured after two courses of treatment.
6, so-and-so, woman, 62 years old of king lives Ma Zhao town, Zhouzhi County, Xi'an group Xing Cun, suffers from lumbar vertebra the 3rd, five joint hyperosteogenys and has a surplus in 10 years, and through acupuncture point block, Chinese medicine, traction, massage are treated for many years and do not healed, and with 4 courses of treatment of this medicine external application for curing, now fully recovers.
The present invention and similar inventions: 93110025.9 compare, the product of its side's medication such as Wu's cornel, monkshood, pericarpium zanthoxyli, hot stimulation, skin had obvious excitant, make many patients can not accept this medicine, and have certain toxic and side effect, the invention has the advantages that skin non-stimulated, have no side effect, five minutes obvious alleviating pains are fundamentally thoroughly treated, and instant effect, short treating period, easy to use.
The present invention compares with used osteoproliferation medicine for oral administration, used medicine for oral administration, long-term taking produces certain side effect and slow curative effect to stomach, think that according to the differential diagnosis in tcm theory single a kind of oral medicinal herb medicine can not adapt to this type of disease for the treatment of fully, the present invention is according to traditional Chinese medical science inner disease outer treat principle, adopt external application of Chinese medicine agent, the direct effect diseased region, absorb the focus that directly becomes by skin histology, dispel old complaint, drug effect is remarkable, rapid swelling and pain relieving, hyperplastic tissue can fully be absorbed minute take off, and have no side effect, easy to use, short treating period, instant effect.
Claims (10)
1, hyperosteogeny application compress, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Ethanol 80-65%.
2, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Ethanol 80-65%.
3, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Ethanol 80-65%.
4, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5%; Ethanol 80-65%.
5, hyperosteogeny application compress according to claim 1, its preparation method is: raw material powder is broken into fine powder crosses 300 mesh sieves and then medicated powder is soaked into for 75% ethanol 1-2 week.
6, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Ethanol 80-65%.
7, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Ethanol 80-65%.
8, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Scorpio 1-1.5%; Eupolyphaga 1-1.5%; Ethanol 80-65%.
9, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Scorpio 1-1.5%; Eupolyphaga 1-1.5%; Camphora 1-1.5%; Radix Angelicae Sinensis 1-1.5%; Pyritum 0.5-1%; Ethanol 80-65%.
10, hyperosteogeny application compress according to claim 1, its prescription is: it mainly comprises Impatientis 1-3%; Folium Et Cacumen Murrayae 1-3%; Gekko Swinhonis 1-2%; Rhizoma Drynariae 2-3%; Borneolum Syntheticum 1-1.5%; Succinum 1-1.5%; Radix Clematidis 1-2%; Olibanum 1-1.5%; Myrrha 1-1.5; Herba speranskiae tuberculatae 1-2%; Sanguis Draxonis 0.5-1.5%; Radix Cyathulae 1-1.5%; Scorpio 1-1.5%; Eupolyphaga 1-1.5%; Camphora 1-1.5%; Radix Angelicae Sinensis 1-1.5%; Pyritum 0.5-1%; Radix Angelicae Pubescentis 0.5-1%; Flos Carthami 0.5-1%; Ethanol 80-65%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02145575 CN1267127C (en) | 2002-12-18 | 2002-12-18 | Osteoproliferation medicine for external application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02145575 CN1267127C (en) | 2002-12-18 | 2002-12-18 | Osteoproliferation medicine for external application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1507892A true CN1507892A (en) | 2004-06-30 |
CN1267127C CN1267127C (en) | 2006-08-02 |
Family
ID=34232504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02145575 Expired - Fee Related CN1267127C (en) | 2002-12-18 | 2002-12-18 | Osteoproliferation medicine for external application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1267127C (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345560C (en) * | 2005-11-16 | 2007-10-31 | 石昆山 | Ointment for treating osteoproliferation and protrusion of intervertebral discand preparing method |
CN102362911A (en) * | 2011-10-20 | 2012-02-29 | 郑同新 | Traditional Chinese medicinal powder for treating sciatica |
CN102935159A (en) * | 2012-12-08 | 2013-02-20 | 南京正宽医药科技有限公司 | Traditional Chinese medicine composition for treating fracture as well as preparation method and application thereof |
CN107213178A (en) * | 2017-06-28 | 2017-09-29 | 邢夺伟 | A kind of Chinese medicine for treating rheumatic overall pain |
-
2002
- 2002-12-18 CN CN 02145575 patent/CN1267127C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345560C (en) * | 2005-11-16 | 2007-10-31 | 石昆山 | Ointment for treating osteoproliferation and protrusion of intervertebral discand preparing method |
CN102362911A (en) * | 2011-10-20 | 2012-02-29 | 郑同新 | Traditional Chinese medicinal powder for treating sciatica |
CN102362911B (en) * | 2011-10-20 | 2013-03-27 | 郑同新 | Traditional Chinese medicinal powder for treating sciatica |
CN102935159A (en) * | 2012-12-08 | 2013-02-20 | 南京正宽医药科技有限公司 | Traditional Chinese medicine composition for treating fracture as well as preparation method and application thereof |
CN102935159B (en) * | 2012-12-08 | 2014-09-10 | 新乡医学院第一附属医院 | Traditional Chinese medicine composition for treating fracture as well as preparation method and application thereof |
CN107213178A (en) * | 2017-06-28 | 2017-09-29 | 邢夺伟 | A kind of Chinese medicine for treating rheumatic overall pain |
Also Published As
Publication number | Publication date |
---|---|
CN1267127C (en) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062194B (en) | Medicine for treating bone disease and fracture and the preparing method thereof | |
CN101797327B (en) | Chinese medicinal preparation for treating pain caused by orthopedic diseases | |
CN102908442B (en) | Composition for treating traumatic injuries and medicinal liquor thereof | |
CN101234153B (en) | Externally-applied medicament for treating bone fracture | |
CN101301406B (en) | Externally applied agent for treating hyperosteogeny, disc herniation, cervical vertebra inflammation and rheumathritis | |
CN1267127C (en) | Osteoproliferation medicine for external application | |
CN103356953B (en) | A kind of Chinese medicine composition for the treatment of lumbar muscle strain | |
CN105726840A (en) | Health essential oil | |
CN103735756A (en) | Traditional Chinese medicinal prescription for treating low back and leg pain | |
CN103599233B (en) | Bone hyperplasia rehabilitation medicinal liquor | |
CN109432309B (en) | Traditional Chinese medicine composition, external medicinal liquor, and preparation method and application thereof | |
CN102579725A (en) | Chinese medicine for heel physiotherapy | |
CN106361895A (en) | Triple-effect syncretic traditional Chinese medicine composition capable of relaxing muscles and tendons, removing obstruction from meridians and relieving pain | |
CN106421255B (en) | External Chinese herbal medicine composition and application thereof | |
CN104771432A (en) | Traditional Chinese medicine for treating fracture | |
CN103735763A (en) | Traditional Chinese medicine composition for treating hyperostosis and cold arthritis and preparation method thereof | |
CN115429869B (en) | Traditional Chinese medicine composition for treating cold-dampness obstruction type lumbago and preparation method thereof | |
CN109289020A (en) | Chinese medicine acupoint magnetic heat orients transdermal | |
CN103550446A (en) | Traditional Chinese medicine composition for external use to treat rheumatoid arthritis and application of traditional Chinese medicine composition | |
CN103721183B (en) | A kind of Chinese medicine composition for the treatment of middle-aged and elderly people lumbago and skelalgia | |
CN114177130B (en) | External preparation for myofascitis and preparation method and application thereof | |
CN108619448A (en) | A kind of plaster and preparation method thereof for treating hyperostosis | |
CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
CN101204533B (en) | Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc | |
CN105267324A (en) | Oral traditional Chinese medicine for treating lumbar vertebra hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |